Normal view MARC view ISBD view

Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma.

Krishnan, Jerry A

Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma. [electronic resource] - JAMA 04 2018 - 1441-1443 p. digital

Publication Type: Editorial; Comment

ISSN: 1538-3598

Standard No.: 10.1001/jama.2018.2029 doi

Subjects--Topical Terms:
Administration, Inhalation
Adrenal Cortex Hormones
Anti-Asthmatic Agents
Asthma
Bronchodilator Agents
Drug Therapy, Combination
Humans
Muscarinic Antagonists
Tiotropium Bromide

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)